Adverse Outcomes of Anticoagulant Use among Hospitalized Patients with Chronic Kidney Disease: A Comparison of the Rates of Major Bleeding Events between Unfractionated Heparin and Enoxaparin

BACKGROUND: Anticoagulation therapy is usually required in patients with chronic kidney disease (CKD) for treatment or prevention of thromboembolic diseases. However, this benefit could easily be offset by the risk of bleeding. OBJECTIVES: To determine the incidence of adverse outcomes of anticoagul...

Descripción completa

Detalles Bibliográficos
Autores principales: Saheb Sharif-Askari, Fatemeh, Syed Sulaiman, Syed Azhar, Saheb Sharif-Askari, Narjes, Al Sayed Hussain, Ali, Railey, Mohammad Jaffar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152258/
https://www.ncbi.nlm.nih.gov/pubmed/25181525
http://dx.doi.org/10.1371/journal.pone.0106517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152258/
https://www.ncbi.nlm.nih.gov/pubmed/25181525
http://dx.doi.org/10.1371/journal.pone.0106517

Ejemplares similares